Circulating SerpinA3 as a novel indicator of cardiovascular dysfunction after anthracycline chemotherapy

Back

ESC Professional Premium Access

Circulating SerpinA3 as a novel indicator of cardiovascular dysfunction after anthracycline chemotherapy

Session: Basic research in cardio-oncology

Topic: Cardio-Oncology

Speaker: Doctor H. Boen (Wilrijk, BE)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Hanne Boen

Wilrijk (Belgium)

1 presentation

0 follower

6 more presentations in this session

Biomimetic nanozymes target the heart to suppress ferroptosis for ameliorating doxorubicin-induced cardiotoxicity via synergetic effect of antioxidant stress and Nrf2/Hmox1 inhibition

Speaker: Professor T. Liu (Tianjin, CN)

Induced pluripotent stem cell-derived cardiac myocytes to assess anthracycline cardiotoxicity

Speaker: Professor L. Van Aelst (Leuven, BE)

Cardiovascular events following vascular endothelial growth factor inhibitor therapy with sunitinib or pazopanib in patients with renal cell carcinoma - a nationwide registry-based follow-up study

Speaker: Doctor J. Shanmuganathan (Aalborg, DK)

Mitochondrial function and oxidative stress in isolated peripheral blood mononuclear cells and trastuzumab-induced cardiotoxicity: a prospective longitudinal study

Speaker: Assistant Professor K. Leemasawat (Chiang Mai, TH)

Protective effects of nicotinamide mononucleotide on radiation-related cardiac injury

Speaker: Professor T. Liu (Tianjin, CN)

Access the full session

Basic research in cardio-oncology

Speakers: Doctor H. Boen, Professor T. Liu, Professor L. Van Aelst, Doctor J. Shanmuganathan, Assistant Professor K. Leemasawat...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources